The development of orally administrable gemcitabine prodrugs with d-enantiomer amino acids: Enhanced membrane permeability and enzymatic stability

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteers

S Weller, Martin Blum, M Doucette et al. · Clinical Pharmacology & Therapeutics · 1993 · 396 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Valacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2

Malliga E. Ganapathy, Wei Huang, Hong Wang et al. · Biochemical and Biophysical Research Communications · 1998 · 295 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +10

Transepithelial Transport of the Bioactive Tripeptide, Val-Pro-Pro, in Human Intestinal Caco-2 Cell Monolayers

Makoto Satake, Masashi Enjoh, Yasunori Nakamura et al. · Bioscience Biotechnology and Biochemistry · 2002 · 236 citations · Full text

Pharmacy, Biochemistry, Pharmacology +14

Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

José Manuel García-Manteiga, Míriam Molina‐Arcas, F. Javier Casado et al. · PubMed · 2003 · 213 citations

Medicine, Oncology, Pharmacology +11

Transport of Amino Acid-Based Prodrugs by the Na+- and Cl--Coupled Amino Acid Transporter ATB0,+ and Expression of the Transporter in Tissues Amenable for Drug Delivery

Takahiro Hatanaka, Masayuki Haramura, You-Jun Fei et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 141 citations

Pharmacy, Pharmaceutics, Pharmacology +12